Abstract
Being able to determine the binding mode of a ligand to DNA, typically base intercalation (BI) or minor groove binding (MGB), is critical to determine the ligand therapeutic effects. Still, drug designers can only gain such information by means of indirect, complicated and very expensive methods [1].
© 2007 IEEE
PDF ArticleMore Like This
Cosimo D’Andrea, Andrea Bassi, Paola Taroni, Daniele Pezzoli, Alessandro Volonterio, and Gabriele Candiani
80871J European Conference on Biomedical Optics (ECBO) 2011
T. Ha, H. P. Babcock, W. Cheng, T. M. Lohman, and S. Chu
CFF3 Conference on Lasers and Electro-Optics (CLEO:S&I) 2000
Paulius Grigaravicius, Rüdiger Dietrich, Wolfgang Fritzsche, Karl Otto Greulich, Uwe Horn, Dietmar Knoll, Sven Peters, Hans –Martin Striebel, and Peter Schellenberg
6633_86 European Conference on Biomedical Optics (ECBO) 2007